SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-050075
Filing Date
2021-08-05
Accepted
2021-08-05 21:22:32
Documents
2
Period of Report
2021-08-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2912
2 EX-24 DOCUMENT attachment1.htm EX-24 3781
  Complete submission text file 0001209191-21-050075.txt   8113
Mailing Address C/O AKERO THERAPEUTICS, INC. 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
Heyman Tomas J. (Reporting) CIK: 0001814673 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40703 | Film No.: 211150342

Mailing Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451
Business Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451 (781) 530-3600
Adagio Therapeutics, Inc. (Issuer) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)